Rocío Isabel
Rodríguez Macías
Catedrática de Universidad
Instituto de Investigación Sanitaria Biodonostia
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biodonostia (10)
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
Cells, Vol. 12, Núm. 16
-
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108
2022
-
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190
2021
2020
-
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters
Biochemical Pharmacology, Vol. 171
2016
-
Mechanisms of resistance to chemotherapy in gastric cancer
Anti-Cancer Agents in Medicinal Chemistry, Vol. 16, Núm. 3, pp. 318-334
2013
-
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
Hepatology, Vol. 58, Núm. 3, pp. 1065-1073